Virtu Financial LLC - CHINA SXT PHARMACEUTICALS IN ownership

CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P132. A total of 7 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of CHINA SXT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$11
-77.1%
39,427
-55.8%
0.00%
-83.3%
Q4 2022$48
-99.8%
89,157
+499.7%
0.01%
+200.0%
Q2 2022$26,00014,8680.00%
Other shareholders
CHINA SXT PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Renaissance Technologies 21,572$17,0000.00%
Hudock, Inc. 300$00.00%
UBS Group AG 7,725$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 45,685$35,0000.00%
HRT FINANCIAL LP 10,870$8,0000.00%
View complete list of CHINA SXT PHARMACEUTICALS IN shareholders